STRATA Skin Sciences, Inc.
SSKN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $92 | $96 | $110 | $111 |
| - Cash | $7 | $6 | $7 | $7 |
| + Debt | $3 | $16 | $16 | $16 |
| Enterprise Value | $88 | $106 | $120 | $120 |
| Revenue | $7 | $8 | $7 | $10 |
| % Growth | -9.6% | 12.5% | -28.9% | – |
| Gross Profit | $4 | $4 | $4 | $6 |
| % Margin | 60.4% | 56.2% | 53.5% | 60.1% |
| EBITDA | -$0 | -$1 | -$1 | -$3 |
| % Margin | -2.5% | -9% | -9.4% | -29.6% |
| Net Income | -$2 | -$2 | -$2 | -$4 |
| % Margin | -23.4% | -32.5% | -35.7% | -47% |
| EPS Diluted | -0.36 | -0.6 | -0.058 | -0.12 |
| % Growth | 40% | -929.2% | 51.4% | – |
| Operating Cash Flow | -$0 | -$2 | -$1 | $1 |
| Capital Expenditures | -$1 | $0 | -$0 | -$1 |
| Free Cash Flow | -$1 | -$2 | -$1 | $0 |